Literature DB >> 29526761

Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis.

Felix Lauffer1, Manja Jargosch2, Linda Krause3, Natalie Garzorz-Stark2, Regina Franz2, Sophie Roenneberg2, Alexander Böhner2, Nikola S Mueller3, Fabian J Theis4, Carsten B Schmidt-Weber5, Tilo Biedermann2, Stefanie Eyerich5, Kilian Eyerich2.   

Abstract

Interface dermatitis is a characteristic histological pattern that occurs in autoimmune and chronic inflammatory skin diseases. It is unknown whether a common mechanism orchestrates this distinct type of skin inflammation. Here we investigated the overlap of two different interface dermatitis positive skin diseases, lichen planus and lupus erythematosus. The shared transcriptome signature pointed toward a strong type I immune response, and biopsy-derived T cells were dominated by IFN-γ and tumor necrosis factor alpha (TNF-α) positive cells. The transcriptome of keratinocytes stimulated with IFN-γ and TNF-α correlated significantly with the shared gene regulations of lichen planus and lupus erythematosus. IFN-γ, TNF-α, or mixed supernatant of lesional T cells induced signs of keratinocyte cell death in three-dimensional skin equivalents. We detected a significantly enhanced epidermal expression of receptor-interacting-protein-kinase 3, a key regulator of necroptosis, in interface dermatitis. Phosphorylation of receptor-interacting-protein-kinase 3 and mixed lineage kinase domain like pseudokinase was induced in keratinocytes on stimulation with T-cell supernatant-an effect that was dependent on the presence of either IFN-γ or TNF-α in the T-cell supernatant. Small hairpin RNA knockdown of receptor-interacting-protein-kinase 3 prevented cell death of keratinocytes on stimulation with IFN-γ or TNF-α. In conclusion, type I immunity is associated with lichen planus and lupus erythematosus and induces keratinocyte necroptosis. These two mechanisms are potentially involved in interface dermatitis.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29526761     DOI: 10.1016/j.jid.2018.02.034

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus.

Authors:  Shuai Shao; Lam C Tsoi; Mrinal K Sarkar; Xianying Xing; Ke Xue; Ranjitha Uppala; Celine C Berthier; Chang Zeng; Matthew Patrick; Allison C Billi; Joseph Fullmer; Maria A Beamer; Bethany Perez-White; Spiro Getsios; Andrew Schuler; John J Voorhees; Sung Choi; Paul Harms; J Michelle Kahlenberg; Johann E Gudjonsson
Journal:  Sci Transl Med       Date:  2019-09-25       Impact factor: 17.956

2.  Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.

Authors:  Zhen-Yu Gao; Lin-Chong Su; Qing-Chao Wu; Jiao-E Sheng; Yun-Long Wang; Yu-Fang Dai; An-Ping Chen; San-Shan He; Xia Huang; Guo-Qing Yan
Journal:  Clin Rheumatol       Date:  2021-09-23       Impact factor: 2.980

3.  Insights into Lichen Planus Pigmentosus Inversus using Minimally Invasive Dermal Patch and Whole Transcriptome Analysis.

Authors:  Jacob Dickman; Michael Howell; Robert Hoopes; Yipeng Wang; Tobin J Dickerson; Michael Bottomley; H Nicholas Shamma; Christine M Rapp; Matthew J Turner; Craig A Rohan; Jeffrey B Travers
Journal:  J Clin Investig Dermatol       Date:  2022-04-05

Review 4.  Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus.

Authors:  Tanja Fetter; Christine Braegelmann; Luka de Vos; Joerg Wenzel
Journal:  Front Med (Lausanne)       Date:  2022-05-30

5.  Tofacitinib in Hypertrophic Lichen Planus.

Authors:  Peter Seiringer; Felix Lauffer; Anna Caroline Pilz; Danielle Boehmer; Tilo Biedermann; Kilian Eyerich
Journal:  Acta Derm Venereol       Date:  2020-07-28       Impact factor: 3.875

6.  Thymoma-associated multiorgan autoimmunity initially manifested by graft-versus-host disease-like erythroderma: Case report and possible therapeutic role of antimalarial drugs.

Authors:  Grace A Hile; Taylor Novice; Jeanne Kochkodan; May P Chan; Johann E Gudjonsson; Milad Eshaq
Journal:  JAAD Case Rep       Date:  2020-06-11

7.  Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an In Vitro Model.

Authors:  Christine Braegelmann; Tanja Fetter; Dennis Niebel; Lara Dietz; Thomas Bieber; Joerg Wenzel
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

Review 8.  Current concepts of photosensitivity in cutaneous lupus erythematosus.

Authors:  Benjamin Klein; Manfred Kunz
Journal:  Front Med (Lausanne)       Date:  2022-08-25

Review 9.  Current translational potential and underlying molecular mechanisms of necroptosis.

Authors:  Tamás Molnár; Anett Mázló; Vera Tslaf; Attila Gábor Szöllősi; Gabriella Emri; Gábor Koncz
Journal:  Cell Death Dis       Date:  2019-11-12       Impact factor: 8.469

10.  Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.

Authors:  Tanja Fetter; Paul Smith; Tugce Guel; Christine Braegelmann; Thomas Bieber; Joerg Wenzel
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.